Search

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

A
Aakhus S. - Left ventricular (LV) thrombus formation in spite of intensive antiplatelet treatment in patients with acute anterior wall st-elevation myocardial infarction (STEMI) treated with PCI
Aarden L. - Factor VII-activating protease is activated in sepsis
Aarset⊘y H. - Would the use of N-terminal pro-B-type natriuretic peptide as a prognostic marker have changed our clinical judgement?
  - Evaluation of plaque destabilization by pregnancy-associated plasma protein a (PAPPA) and coagulant activity did not predict reccurent Troponin-T positive cardiac events following an acute myocardial infarction
Aaspollu A. - Haemostasis affecting proteases from vipera lebetina snake venom
Ababneh B.A. - Venous thromboembolism (VTE) risk stratification in hospitalized cancer patients
Abad-Franch L. - Gynecologic and obstetric pathologies in women with severe bleeding disorders: experience at a reference coagulopathies unit in spain
  - Phenotype-genotype correlation in mild hemophilia A
  - Menorrhagia in women with von Willebrand disease: experience in a reference congenital coagulopathies unit in Spain
Abalotti C. - Procoagulant phospholipids in patients with venous thromboembolism and cancer
  - Thrombin generation in carriers of inherited clotting inhibitors defects
Abasolo N. - Association study between variants in GAS6-TAM genes and atheroma carotid plaque
Abate M. - Obesity, poor muscle strength and the risk of venous thromboembolism in older persons: the inchianti study
Abate C. - Improvement of the specificiy and diagnostic utility of a D- dimer (Dd) test for deep vein thrombosis (DVT) exclusion using different cut-off levels according to age and gender
Abbate R. - Monitoring platelet function in coronary heart disease patients on clopidogrel therapy: whole blood multiplate impedance aggregometer compared to classical and new platelet function methods
  - Different pattern of modifications for haematopoietic and endothelial progenitor cells after a strenuous exercise in sedentary healthy men
  - Modifications of reticulocytes and reticulated platelets in sedentary healthy men after an acute episode of strenuous exercise
  - Influence of alcohol beverages and drinking pattern on homocysteine concentrations
  - Effect of short-term consumption of bread obtained by a selected ‘healthy’ Italian grain variety on lipid, inflammatory and haemorheological variables: an intervention study
  - Effect of a diary product (pecorino cheese) naturally rich in CIS-9, TRANS-11 conjugated linoleic acid on lipid, inflammatory and haemorheological variables: an intervention study
  - Hemorheological profile in peripheral arterial disease patients
  - Platelet reactivity in stable atherosclerotic disease patients on chronic antiplatelet treatment
  - ACE D/-240T haplotype modulates the predisposition to peripheral arterial disease
  - Balance between circulating endothelial progenitor cells (EPCs) and mature circulating endothelial cells (CECs) in relation to the severity of peripheral arterial disease
  - Transthoracic echocardiography in patients with a first episode of pulmonary embolism (PE) for the detection of chronic thromboembolic pulmonary hypertension (CTPH)
  - Reticulated platelets and platelet reactivity in renal trasplant recipients on antiplatelet therapy
  - Platelet aggregability is modulated by eNOS locus in non-type 2 diabetic patients with acute coronary syndrome
  - A hypofibrinolytic state is associated with retinal vein occlusion
  - Hyperhomocysteinemia and risk of venous thromboembolism recurrence after a first episode of pulmonary embolism
  - Obesity as a possible risk factor for incomplete restoration of pulmonary perfusion after pulmonary embolism (PE)
  - Relevant risk of bleeding in atrial fibrillation patients on warfarin waiting for elective cardioversion
  - Bleeding risk during oral anticoagulation in atrial fibrillation patients older than 80 years
  - Stroke risk in atrial fibrillation patients on warfarin: predictive ability of risk stratification schemes for primary and secondary prevention
  - Bone marrow-derived progenitor cells in ischemic stroke patients: relationship between infarct size, neurological impairment and discharge outcome
  - Hematocrit and erythrocyte deformability affect ADP platelet reactivity in patients with acute coronary syndromes on dual antiplatelet therapy
  - Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients are predicted by residual platelet reactivity to ADP in the absence of CYP2C19∗2 allele: beyond genetic screening
  - Cytochrome P450 2C19 polymorphism and cardiovascular recurrences in patients under clopidogrel treatment: a meta-analysis
  - Homocysteine, B-group vitamins (vitamin B6 and folic acid) and rheological parameters as independent risk factors for retinal vein occlusion
  - High lipoprotein (a) levels are associated with an increased risk of retinal vein occlusion
  - Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment
  - Comparison of whole blood multiplate impedance aggregometry with platelet function tests to assess residual platelet reactivity
  - Effect on light transmittance aggregation of adjustment of platelet count in platelet-rich plasma in patients on dual antiplatelet therapy
  - Platelet aggregation in whole blood: sodium citrate or hirudin as anticoagulant?
  - Platelet function assessment by multiple electrode whole blood aggregometry in high risk patients with coronary artery disease on antiplatelet therapy
  - Assessment of quality control and accuracy of portable coagulometers for monitoring oral anticoagulant treatment in anticoagulation clinic
  - Protein Z levels and thrombotic diseases – a meta-analysis
  - Effect of a personalized physical activity programme on weight reduction and endothelial progenitor cells in overweight subjects
  - Clopidogrel nonresponsiveness and risk of cardiovascular morbidity – an updated meta-analysis
  - Close monitoring of hemostasis by thromboelastometry during extracorporeal membrane oxygenation (ECMO)
  - Low-dose aspirin therapy after kidney transplantation
Abbott D. - Quantitative trait loci (QTL) for von Willebrand factor (VWF) levels in a large pedigree with von Willebrand disease (VWD)
Abbott L.S. - The impact of prophylactic cryoprecipitate and fresh frozen plasma on the incidence of CNS thromboses in children with acute lymphoblastic leukemia (ALL) receiving asparaginase
Abboud M. - Use of recombinant activated factor vii in pediatric patients without hemophilia
  - Inherited thrombophilia in childhood stroke: experience of a tertiary care center in lebanon
Abd El-Fadeel Ragab M. - Role of tissue factor pathway inhibitor (TFPI) as a predictor of disseminated intravascular coagulopathy (DIC) among children with sepsis syndrome
Abd Karim F. - VWF:CB and VWF:RCo. Assay to differentiate between type 1 and type 2 von Willebrand disease in national blood centre
Abdel Gader A.M. - Fondaparinox for a pregnant woman with deep vein thrombosis and heparin allergy
Abdelgadir A.M. - Natural anticoagulants can be useful predictors of severity in chronic liver disease
  - The peculiar platelet behavior in the arabian camel (camel dromedarius)
Abdelkarim R. - The avail me project: a first regional evaluation of venous thromboembolism (VTE) risk and prophylaxis practice
Abdel-Razeq H.N. - Venous thromboembolism (VTE) in hospitalized cancer patients: prophylaxis failure or failure to prophylax?
  - Venous thromboembolism (VTE) risk stratification in hospitalized cancer patients
Abderrazak F. - Platelet glycoprotein IIB/IIIA polymorphism and risk of cardiovascular events in aspirin-treated patients with stable coronary artery disease
Abdihakim A. - ACE D/-240T haplotype modulates the predisposition to peripheral arterial disease
Abdo A.A. - Natural anticoagulants can be useful predictors of severity in chronic liver disease
Abdul F Karim  - Congenital factor V deficiency: malaysia experience
Abdulkadirov K.M. - Prevalence of hyperhomocysteinemia in patients with multiple myeloma
Abdullahi Said A. - Platelet aggregation in whole blood: sodium citrate or hirudin as anticoagulant?
Abe M. - D-dimer test for diagnosis of deep venous thrombosis (DVT) in the ICU
Abe Y. - Elevated levels of soluble fibrin in patients with venous thromboembolism
Abe K. - Reconstructed recombinant factor Xa as an antidote to reverse anticoagulation by factor Xa inhibitors
Abegunde S.O. - Haemostatic and haemorheological changes in african patients with acute lymphoblastic leukaemia
  - Haemostatic and haemorheological changes in African patients with chronic myeloid leukaemia
Abel K. - Glycopegylated human recombinant factor IX showed prolonged haemostatic activity in cynomolgus monkeys
Aberson H. - A mechanism for thrombin-dependent lung metastasis in patients with osteosarcoma
  - FXA-induced intracellular signaling links coagulation to neoangiogenesis: potential implications for fibrosis
Abgral R. - Validity of angular sum as planar extraction technique of lung ventilation-perfusion SPECT data
Abgrall J. - Computer modelisation of the prothrombin time test. Conception, validation and potential of application
Abgrall J.F. - Influence of the endothelial cell protein C receptor (EPCR) gene (PROCR) on protein C deficiency expression
Abgrall J. - Elevated thrombin generation in relatives of patients with unprovoked venous thromboembolism and no detectable thrombophilia
Abi-Ayad C. - Severe bleeding due to acquired hypoprothrombinemia-lupus anticoagulant syndrome: case report and review of literature
Abinet I. - Detection of large rearrangements by MLPA in severe hemophilia A patients
Abletshauser C. - Thromboprophylaxis with certoparin in acutely ill, non-surgical patients – certain study
  - Identification OF coagulation parameters which determine the combined effect of low-molecular-weight heparin certoparin and phenprocoumon in patients undergoing cardioversion for recent atrial fibrillation
Abolghasemi H. - In vitro properties of blood bank produced fibrin sealants from single donor human plasma
Abou-Saleh R.H. - The effect of blood coagulation factor XIII on fibrin clot structure and function
Abousamra N.K. - Evaluation of some hemostatic parameters in patients with end-stage renal disease: relation to dyslipidemia and hemodialysis therapy
  - Evaluation of some hemostatic parameters in patients with end-stage renal disease: relation to dyslipidemia and hemodialysis therapy
Abrahams J.M. - Expression of TF and pars on smooth muscle vascular progenitors defines a pattern of CD34+ mobilisation associated with intimal hyperplasia post-transplantation
  - Neointimal cells in transplant arteriosclerosis resemble a specific subset of smooth muscle progenitor cells found circulating post-transplantation
  - Regenerative repair after endoluminal injury associated with inhibition of tissue factor activity on a specific subpopulation of smooth muscle progenitors
Abrams S.T. - Development of new assays to identify the CRP-VLDL complex
Abrams S. - CRP-VLDL complexes in sepsis
Abriss D. - Factor IX variants with factor VIII inhibitor bypassing activity
Abshire T.C. - Novel factor VIII mutations in US hemophilia patients: relationship to ethnicity and inhibitor history
  - Inhibitor surveillance and mutation analysis in hemophilia B patients
Abslander G. - Heparin-induced thrombocytopenia: comparison between the standard gel-particle assay and the functional flow cytometric assay
Abulata N. - Thrombophilic gene mutation in recurrent miscarriage
Aburima A.A. - Nitric oxide induces vasodilator-stimulated phosphoprotein phosphorylation by protein kinase G-dependent and independent mechanisms: role of protein kinase C
Aburubaiha Z.A. - Construction of a new helper vector for the production of helper-dependent adenovectors for the use in hemophilia a gene therapy
Acaia B. - Why do we evaluate pt and aptt before delivery?
Acevedo M. - Inverse correlation between plasma and platelet cholesterol concentration with platelet tissue factor-dependent clotting activity
Achenbach T. - Successful therapy of an extensive vena cava superior thrombosis with intravenous low molecular weight heparin (dalteparin)
Ackermann B. - Natural history and economic burden of ITP in Germany
Acuña S. - Parallel decreases of intraplatelet von Willebrand factor (VWF) and plasminogen activator inhibitor-1 (PAI-1) may determine the bleeding phenotype of type 1 von Willebrand disease (VWD)
Adam M. - Protein Z/protein Z-dependent protease inhibitor complex is a poor inhibitor of factor Xa in a plasma milieu
Adam S. - Thrombin generation and fibrin clot formation in patients with sickle cell disease (SCD)
  - Activation of coagulation in sickle cell trait; possible role for circulating microparticle tissue factor
Adam F. - Antithrombotic and antifibrinolytic effects of platelet protease nexin-1
  - The mitogen-activated protein kinase JNK1 is involved in platelet function and thrombus growth
Adamczuk Y. - The importance of appropriated criteria for lupus anticoagulant (LA) diagnosis
Adamczuk Y.P. - ABO blood group as a risk factor for venous thrombosis
Adamo M. - Development of FC-gamma-RIIA antagonist
Adams G. - Thrombostatin compounds-inhbition of prostate cancer in vitro and in vivo
Adams G.N. - Prolylcarboxypeptidase murine hypomorphs are hypertensive and prothrombotic
Adamson P.J. - The role of the fibrinogen alpha chain in enhancing FXIII activation
Adamson U. - Effects of atorvastatin on haemostasis in patients with type 1 diabetes
  - Glycemic control is of major importance for fibrin clot structure in type 1 diabetes
Adamson P.J. - The role of barrels 1 and 2 in enzymatic activity of factor XIIIa
Addad F. - Platelet glycoprotein IIB/IIIA polymorphism and risk of cardiovascular events in aspirin-treated patients with stable coronary artery disease
Adebayo A.O. - Effects of anti-retroviral therapy on haemostatic and haemorheological parameters in HIV/AIDS patients
Adelmeijer J. - Development of a severe Von Willebrand facator/ADAMTS13 dysbalance during liver transplantation
Adeyemi A.A. - Hemostasis and hematological thrombotic risk factors in young Nigerian SemiVegetarians
  - Anthropometric and haemostatic cardiovascular risk in young Nigerian semi vegetarians
Adiguzel C. - Increased antithrombotic and bleeding effects of contaminated heparins; hematological implications
  - Fibrin clot formation differs in the presence of branded and generic enoxaparins
  - Upregulation of procalcitonin in cancer patients with venous thrombosis
  - Molecular and functional heterogeneity in contaminants isolated from recalled heparin. Impact on anticoagulation and potential adverse reactions
  - Fibrinokinetic deficit in chronic kidney disease and end stage renal disease patients contributes to the hemostatic abnormalities
  - Increased levels of anaphylatoxin (C5a) and bradykinin in end-stage renal disease patients on maintenance hemodialysis. potential relevance to heparin mediated hemodynamic responses
  - Immunogenicity of low molecular weight heparins and biosimilars
  - Assay dependent variations in the USP potency standardized unfractionated heparins
  - Differential thrombin generation inhibition by branded and generic low molecular weight heparins (LMWHs) as studied by using fluorescence substrate based kinetic method
  - Generic versions of argatroban can be differentiated from branded argatroban in the thrombin generation assays (TGA)
  - Activation of prekallikrein by contaminated heparins, isolated contaminant and related hypersulfated chondroitin sulfate preparations: pharmacologic implications
  - A higher prevalence of hit antibodies in hemodialysis patients may be due to contaminated heparin
  - Contaminants in heparin: a call for substitute anticoagulants
  - Defibrotide augments the anticoagulant actions of heparin and low molecular weight heparins
  - Bioavailability of over sulfated chondroitin sulfate. Immunologic implications
Adjali M. - Haemostatic management of post surgical severe bleeding using low doses of FVIII/VWF concentrate in type 3 von Willebrand disease
Adraktas T. - Follow up of TTP patients and results of splenectomy in relapsing cases. experience of one centre
Advate PASS Study Group  - Post-authorization safety surveillance (PASS) program of antihemophilic factor (recombinant), plasma/albumin-free method (RAHF-PFM) for Japanese hemophilia A patients
Afandi F.M.D. - VWF:CB and VWF:RCo. Assay to differentiate between type 1 and type 2 von Willebrand disease in national blood centre
Afink G.B. - Caspase 3 is sorted into microparticles from MCF-7 cells
Afrasiabi A. - Frequency of hereditary thrombophilic risk factors in Iranian patients with deep vein thrombosis
Agaoglu L. - Plasma levels of plasminogen activator inhibitor type 1 and vitronectin in children with solid tumors
Agar C. - The lipoprotein distribution of Beta-2-Glycoprotein I (apolipoprotein H)
Ageenkova A.V. - Intracranial bleedings in children with ITP
  - Factors of extracerebral non cathether related thrombosis in children
Ageno W. - Agreement of perfusion scintigraphy and CT-angiography in detecting residual thromboemboli after pulmonary embolism
  - The effect of thyroid autoantibodies on warfarin stability: retrospective inception cohort study
  - Evaluating the feasibility of less frequent INR testing during chronic anticoagulation therapy
  - Incidence and predictors of serious bleeding following polypectomy in patients receiving and not receiving oral anticoagulation therapy
  - A randomized, prospective, open-label study on distal vein thrombosis (low-molecular-weight heparin vs. warfarin for 6 weeks): the todi study
  - JAK2V617F mutation in patients with arterial thrombosis in the absence of overt myeloproliferative disease
  - Incidence of cardiovascular events after venous thromboembolism. A systematic review and meta-analysis
  - Metabolic syndrome is a risk factor for venous thromboembolism in KOREAN population
  - Natural history of mesenteric venous thrombosis in patients treated with oral anticoagulants
  - JAK2V617F mutation for the early diagnosis of Ph-myeloproliferative neoplasms in patients with venous thromboembolism. a meta-analysis
  - Prognostic relevance of asymptomatic VTE in cancer patients
  - LMWH vs. aspirin for the treatment of acute retinal vein occlusion
  - Multidetector computed tomography to assess clinical outcome in hemodynamically stable patients with acute pulmonary embolism
Agerkvist I. - Characteristics of the first human cell line recombinant human factor VIII (human-cl rhFVIII)
Agerso H. - Pharmacokinetic (PK) evaluation of a new RFVIII (N8) after i.v. administration of different dose levels to FVIII knock-out mice
  - Pharmacokinetic (PK) and pharmacodynamic (PD) properties of a new recombinant FVIII (N8) in hemophilia a dogs
Agersoe H. - The pharmacokinetics of a long-acting factor ix (40K PEG-RFIX) in minipigs suggests at least a once-weekly dosing regime
Aghighi S. - Comparison of three different thrombin generation assays in patients with haemophilia
  - Different one stage FVIII activity results in a patient with moderate haemophilia a depending on the type of aptt reagent used
Aghili M. - The avail me project: a first regional evaluation of venous thromboembolism (VTE) risk and prophylaxis practice
Agic D. - Off label use of recombinant factor viia in the hematology ward
Agnelli G. - Incidence of cardiovascular events after venous thromboembolism. A systematic review and meta-analysis
  - Hemostatic variables in cancer patients receiving low-molecular-weight heparin (LMWH) nadroparin or placebo during chemotherapy in the protecht trial
  - Computer assisted VKA monitoring with point of care device by general practitioners
  - Prospective assessment of clinical endpoints of VKA treatment in a primary care computer assisted management model
  - Prevention of thromboembolic events in advanced lung cancer patients receiving chemotherapy: a combined analysis from protecht and topic-2 studies
  - Multidetector computed tomography to assess clinical outcome in hemodynamically stable patients with acute pulmonary embolism
  - Prognostic relevance of asymptomatic VTE in cancer patients
  - Antithrombotic prophylaxis for laparoscopic cholecystectomy: a meta-analysis
Agnelli G.G.A. - The Italian pulmonary embolism registry “IPER”: preliminary results
Agnelli G. - Venous thromboembolism recurrence after a first episode of provoked venous thrombosis due to a transient risk factor. A systematic review of the literature
Agostini M. - A retrospective and prospective single centre study on applicability of the proposed wraige classification for subtypes of arterial ischemic stroke (AIS) in children
Agrawal S.G. - Predictors of cardiovascular disease in pre-eclampsia
Agriello E. - Platelet aggregation and coagulation disorders in ehlers-danlos syndrome
Agterof M.J. - The quality of anticoagulant therapy in the initial treatment period of patients with pulmonary embolism
  - N-terminal pro-brain natriuretic peptide correlates with the percentage of pulmonary vascular obstruction in patients with acute pulmonary embolism
  - Risk stratification of patients with pulmonary embolism based on pulse rate and D-dimer concentration
Aguilar S. - Evaluation of a new kit for quantitation of platelet associated immunoglobulins
Aharon A. - The role of microparticles (MPs) in diabetic vascular complications
  - Microparticles affect angiogenesis and inflammation balance– in healthy pregnancies and gestational vascular complications
AHCD C. - phenotypic and genotypic characterization of a Canadian cohort of type 3 von Willebrand disease (VWD) patients
  - Comparative analysis of von Willebrand Factor multimers from the Canadian type 1 VWD study
Ahluwalia J. - Lupus anticoagulant in a child with celiac disease – an uncommon association
  - Recurrent thrombosis in north Indian patients and the role of thrombophilic risk factors
  - Anticardiolipin antibodies and lupus anticoagulant in children with systemic lupus erythematosus – the North Indian experience
  - Study of inherited and acquired prothrombotic risk factors in pediatric patients with thrombosis
Ahmad F. - Thrombogenic mutations in glanzmann's thrombasthenia patients
  - Mutation spectrum and molecular studies of type 2 von Willebrand disease
Ahmad R.U. - The residence of FVIII-specific memory B cells in hemophilic mice after intravenous application of FVIII
  - Towards a new hemophilic mouse model for the detection of neo-antigen formation in human factor VIII
  - Opportunities and limitations of mouse models humanized for HLA class II antigens
Ahmadian L. - Frequency of factor V Leiden and Prothrombim 20210A as thrombotic and genetic risk factors for preeclampsia in the South Iranian province
Ahmadian H. - Downstream processing of pegylated rFVIIa
Ahmadinejad M. - A comparison of the prevalence of hereditary natural anticoagulant pathway defects between patients with DVT, PE and thrombosis at unusual sites
Ahmadinejad T. - A comparison of the prevalence of hereditary natural anticoagulant pathway defects between patients with DVT, PE and thrombosis at unusual sites
Ahmadkia daliri A. - The impact of inhibitors on the cost of clotting factor replacement therapy in hemophilia A in south of Iran
Ahmed F. - Bone mineral density in children with severe haemophilia receiving regular FVIII prophylaxis
Ahmed M. - Validation of rapid and automated method for measurement of ADAMTS-13 activity and auto antibodies
Ahmed A. - Coagulopathy secondary to niacin therapy
Ahmidatou H. - Acquired factor X deficiency: difficulties to establish etiologic diagnosis
Ahrens I. - Simultaneous direct factor Xa inhibition and activated platelet blockage allows superior anticoagulation without bleeding time prolongation
Aiach M. - In vivo and in vitro effect of a new thrombin protease-activated receptor (PAR-1) antagonist
  - Influence of the genetic status on endothelial cell protein C receptor (EPCR) mRNA forms from peripheral blood mononuclear cells (PBMC), and on soluble EPCR (sEPCR) levels
  - Endothelial progenitor cells are selectively mobilized immediately after coronary artery bypass grafting or valve surgery
  - Influence of the endothelial cell protein C receptor (EPCR) gene (PROCR) on protein C deficiency expression
Aida K. - Evaluation of aspirin resistance in aspirin-free patients with severe type-2 diabetes mellitus
Aikawa E. - Atherosclerosis-associated LY-6Chi blood monocytosis impairs wound healing in mice with myocardial infarction
Aillaud M.F. - Influence of the endothelial cell protein C receptor (EPCR) gene (PROCR) on protein C deficiency expression
Aisina R. - Role of kringles of plasminogen (Pg) and plasmin-staphylokinase activator complex (Pm-STA) in ternary enzyme-substrate complex formation
Aisina R.B. - Mechanism of inhibitory action of angiostatin on plasminogen (PG) activation by tissue plasminogen activator (TPA) and urokinase (UPA)
Aisina R. - The effect of tranexamic acid and captopril on inflammatory process
Aissaoui H. - mda-9/Syntenin promotes active tissue-factor/FVIIa complex assembly and mediates tumor cell migration and invasion
Aïtchafa Tadlaoui D. - A clinical case of hemoglobin c disease, protein s deficiency and leukemia
  - Haemostasis and pregnancy. preliminary study in an algerian hospital
Aitken E.W. - Antagonists of integrin GPIIB/IIIA paradoxically enhance GPVI-induced platelet activation, revealing a feedback signalling pathway from integrin to GPVI involving the protein tyrosine phosphatase PTP1b
Aivado M. - A phase III, double-blind, placebo-controlled study (RAISE) of eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura (ITP)
Aixalá M. - Severe bleeding, cryofibrinogenaemia (CF) and rheumatoid arthritis (RA)
Ajayi O.I. - Hemostasis and hematological thrombotic risk factors in young Nigerian SemiVegetarians
  - Anthropometric and haemostatic cardiovascular risk in young Nigerian semi vegetarians
Ajayi I.O. - Reduced fibrinolysis in women after delivery
  - Contrast media induced fibrinolysis and hypofibrinogenaemia in Nigeria intravenous pyelography (IVP) patients
  - Haemostatic and haemorheological changes in african patients with acute lymphoblastic leukaemia
  - Haemostatic and haemorheological changes in African patients with chronic myeloid leukaemia
Ajjan R.A. - Clotting factors, inflammatory markers and glycemic control in diabetes: role in clot structure and fibrinolysis
  - Ala312Thr polymorphism is not associated with changes in clot structure in a recombinant system: pitfalls in analyzing plasma-purified protein
Ajjan R. - Fibrinogen Birmingham II – a novel variant associated with hypodysfibrinogenemia, due to compound heterozygosity for Trp334Cys and Asn335Tyr in the fibrinogen A alpha chain
Ajjan R.A. - Aspirin and cardiovascular disease: a cyclooxygenase-independent mode of action
  - Fibrin structure/function in relation to stroke sub-types and post-stroke mortality
Ajzenberg N. - First case of constitutional GVI defect in a patient heterozygous for two GPVI mutations
Akagi E.M. - Kunitz type inhibitor (rKTI) induces changes in gene expression, proteasome inhibition and apoptosis in cancer cells
Akar N. - Effect of homocysteine on endothelial protein C receptor
Akarsu S. - Paraoxonase-1 L/m 55 gene polymorphism in the cases of idiopathic thrombocytopenic purpura
  - eNOS Glu298Asp gene polymorphism in the cases of idiopathic thrombocytopenic purpura
Akasaka T. - Impact of in vivo platelet activity on subclinical stent thrombosis: an optical coherence tomography study
Akassaglou K. - Reduction of prothrombin in mice attenuates the development of paralysis associated with experimental autoimmune encephalomyelitis
Akassoglou K. - Fibrinogen signal transduction in the nervous system
Akay O.M. - Unique whole blood gene expression profiles distinquish different clinical phenotypes of venous thromboembolism
Akbar H. - Rho GTPases Rac1 and RhoA differentially regulate platelet actin reorganization, secretion and aggregation
  - Anti-diabetic small molecule 1,2,3,4,6-penta-o-galloyl-α-d-glucopyranose inhibits platelet activation by preventing Giα2-mediated signal transduction
Akcay A. - The comprehensive, multidisciplinary team for the treatment of haemophilia: istanbul experience
  - RFVIIA treatment in factor VII deficiency: a single centre experience
  - Immun thrombocytopenic purpura in children with therapy modalities
Akdogan M. - Topical ankaferd blood stopper administration to bleeding gastrointestinal carcinomas can control local hemorrhage and decrease tumor vascularization
Akhremitchev B.B. - Forced rupture of fibrin ‘A-a’ knob-hole interaction is accompanied by unfolding in the distal D region of the molecule
Akhter M.S. - Fibrinogen polymorphisms and the risk of acute onset ischemic stroke in young Asian Indians
  - eNOS polymorphisms may be a risk factor for deep vein thrombosis in Indian Asian population
Akhvlediani M. - Application of low molecular-weight heparin in pregnant women
Akiba E. - The cHS-4 chromatin insulator sequence protects clonal dominance of hematopoietic stem cells transduced with a self-inactivating SIV vector in platelet-directed gene therapy
Akici F. - RFVIIA treatment in factor VII deficiency: a single centre experience
  - The comprehensive, multidisciplinary team for the treatment of haemophilia: istanbul experience
  - Immun thrombocytopenic purpura in children with therapy modalities
Akinshina S.V. - Prevention of recurrent preeclampsia in women with thrombophilia
  - Pregnancy management in women with history of obstetric complications and thrombophilia
  - Catastrophic antiphospholipid syndrome and obstetric complications
  - Role of thrombophilia in prosthetic valve thrombosis during pregnancy
  - Pregnancy in women with history of stroke: pathogenetic prophylaxis is possible
  - Polymorphisms of proinflammatory cytokines, genetic thrombophilia and antiphospholipid syndrome in pathogenesis of thrombotic complications of hormonal replacement therapy
Akiyama M. - Presence of platelet-associated anti-GPVI autoantibodies and restoration of GPVI expression in patients with GPVI deficiency
  - Crystal structure of the exosites-containing fragment of ADAMTS13
Akkerman J.N. - The HDL receptor SR-BI modulates platelet function and susceptibility to thrombosis in vivo
  - Mlck1a is expressed in zebrafish thrombocytes and an essential component for thrombus formation
Akkerman J.W.N. - Induction of insulin resistance by adipokines in human megakaryocytes
  - Effect of glycoprotein Ibalpha clustering on platelet clearance in vivo
  - Role of glycoprotein Ibalpha mobility in platelet function
  - Tissue factor pre-mRNA splicing in platelets from healthy subjects and type 2 diabetes mellitus patients
  - An in vitro model to visualize and quantify phagocytosis of platelets and vWF
Akrami M. - Induction of catalytic activity of plasminogen by monoclonal antibody A5E10 in the presence of plasminogen activators
Akria L. - Assesment of thrombotic risk in patients with PV/ET by TEG: judicious use of low dose aspirin in thrombosis prophylaxis
Aksöyek A. - Evaluation of hematologic factors in young and elderly candidates for coronary artery bypass grafting
Aksu S. - The value of early treatment in patients with haemophilia and inhibitors
  - T33P substitution and W519X mutation in two turkish patients with FXI deficiency
Akulich N.V. - High-risk atherosclerosis of mogilev schoolchildren
Al Dieri R. - The procoagulant effect of Vitamin-K antagonists in patients with atrial fibrillation, atherosclerosis and deep venous thrombosis
  - High procoagulant activity in subretinal fluid in primary retinal detachment disorder
  - Comparison of the haemostatic and prothrombotic activities of different factor IX preparations by means of the thrombin generation test
  - Calibrated thrombin generation from a single measuring well
Al Duhgyal M. - Natural anticoagulants can be useful predictors of severity in chronic liver disease
Al Ghomlas A.K. - The peculiar platelet behavior in the arabian camel (camel dromedarius)
Al Ghumlas A.K. - Natural anticoagulants can be useful predictors of severity in chronic liver disease
Al Haidari A. - The peculiar platelet behavior in the arabian camel (camel dromedarius)
Al Harthi A. - Successful treatment of a case of catastrophic antiphospholipid syndrome with autologous bone marrow transplantation
  - Inferior vena caval filter insertion – 5 year experience in a tertiary care hospital
Al Mohareeb F. - Successful treatment of a case of catastrophic antiphospholipid syndrome with autologous bone marrow transplantation
Al Nounou R. - Validation of rapid and automated method for measurement of ADAMTS-13 activity and auto antibodies
Al Sania F.M. - Natural anticoagulants can be useful predictors of severity in chronic liver disease
Al Sawat K. - Natural anticoagulants can be useful predictors of severity in chronic liver disease
Al Zahrani H. - Successful treatment of a case of catastrophic antiphospholipid syndrome with autologous bone marrow transplantation
Ala F.A. - 12 novel factor IX mutations identified in Iranian haemophilia B patients
Ala F. - Plasma homocysteine level and MTHFR mutation in Iranian patients with thrombotic events
  - Detection of 101 novel mutations in the factor 8 gene of Iranians hemophilia A patients
  - Molecular analysis of type 2 von Willebrand Disease in Iranian patients
Alam S. - Predictors of cardiovascular disease in pre-eclampsia
  - The influence of CYP2C9 genetic polymorphisms on oral anticoagulant dose requirements in the lebanese population
Alamelu J. - Quality of life in patients with severe haemophilia A and inhibitors on PDFVIII
Alatri A. - Prolonged coagulopathy related to anticoagulant superwarfarin rodenticides overdose
  - Prevention of venous thromboembolism in pregnant women: management strategy on a large health care area
  - Low molecular weight heparins laboratory monitoring: variability in relation to calibration and antithrombin plasma level
  - D-dimer time course after stopping anticoagulation after a first episode of idiopathic venous thromboembolism: the PROLONG II prospective study
  - D-dimer and comorbidities as risk factors for recurrence after a first episode of venous thromboembolism in the extended follow-up of the prolong study
  - D-dimer and age as risk factors for recurrence after a first episode of venous thromboembolism in the extended follow-up of the prolong study
  - D-dimer and sex as risk factors for recurrence after a first episode of venous thromboembolism in the extended follow-up of the prolong study
  - Usefulness of venometer test in outpatient with clinical suspicion of deep vein thrombosis
Al-Awadhi A.M. - Determination of adamts-13 and vWF antigen and activity levels in patients with thrombotic thrombocytopenic purpura and other thrombocytopenic disorders in kuwait
Alba L. - Recombinant activated factor VII prophylactic treatment for intracranial hemorrhage in a hemophilia patient with inhibitors
Alba R. - Selected modification of the adenovirus type 5 hexon modulates interaction with coagulation factor X and hepatocyte transduction in vivo
Alban S. - A fluorescence microplate assay for direct quantification of heparins and other sulfated carbohydrates
  - Prothrombin time as a simple screening method to identify heparins contaminated with OSCS and similar compounds
  - Development of a novel heparanase activity assay and identification of potent heparanase inhibitors
Albanez S. - Factor VIII gene mutations in patients with severe hemophilia A and inhibitors from Venezuela
Albanyan A. - Application of dynamic light scattering to the measurement of microparticles
Albar J.P. - LC-ESI-MS/MS analysis of Y1680 sulfonation in recombinant FVIII concentrates
Albayrak G. - Results of a multicenter, cross-sectional venous thrombosis screening study in Izmir
Albayrak D. - Immune thrombocytopenic purpura-related hemotympanum presenting with hearing loss
Albayram S. - Acute promyelocytic leukemia treated with idarubisin complicated by focal segmental glomerulosclerosis
Alber M. - Why do thrombi stop growing? – fibrin polymerization may limit clot growth
Alberio L. - Impaired thrombin scavenging may lead to thromboembolic complications in afibrinogenemia: a case report
  - The effect of ddavp on platelet function: selective enhancement of platelet procoagulant activity
  - Diagnostic value of platelet flow-cytometric analysis in patients with clinically relevant bleeding diathesis and unrevealing laboratory work-up
  - Low-dose recombinant factor VIIa for life-threatening bleeding is efficacious even at low fibrinogen levels
  - Variability of anti-PF4/Heparin antibody results obtained by the rapid testing system id-H/PF4-PaGIA
Alberti S. - Platelet activation and platelet-leukocyte mixed conjugates in patients with atrial fibrillation
Alberto M.F. - Plasma glutathione peroxidase (GPx-3) and apolipoprotein (a) (APOa) in young patients with non-embolic ischemic stroke (IS): a sub-group analysis
  - B2 Glycoprotein I (B2GPI) containing IGM immune-complexes (B2GPI-IGM IC) in patients with IGM anticardiolipin antibodies (ACL IGM)
Alberto F. - Severe bleeding, cryofibrinogenaemia (CF) and rheumatoid arthritis (RA)
Alberto M. - Release of pentraxin-3 from activated neutrophil modulates platelet-neutrophil cross-talk
Alberto M.F. - Effect of nytroxyl and nitric oxide on the oxidative status in normal platelets
  - An in vitro study about the combined antiplatelet effects of cilostazol and aspirin
  - Prospective epidemiological study of thrombophilia and inflammation markers in young hispanic patients with arterial thrombosis
Alberts P. - EV-077-3201-2TBS, a reversible dual thromboxane receptor antagonist and thromboxane synthase inhibitor, is more potent than aspirin in inhibiting arachidonic acid and collagen-induced human platelet aggregation in vitro
Albisetti M. - Outcome of catheter-related arterial thrombosis in children
  - Incidence and risk factors of catheter-related arterial thrombosis in children
Albors M. - Utility of the impedance aggregometry with multiple electrodes (mea) in diagnosis of von Willebrand disease (VWD)
Albrecht S. - Interaction of TF with endothelial cells
Alcalá Pedrajas J.N. - Major bleeding events in stable outpatients with coronary, cerebrovascular or peripheral artery disease. findings from the frena registry
Aldeshev A. - The avail me project: a first regional evaluation of venous thromboembolism (VTE) risk and prophylaxis practice
Aledort L.M. - Variable platelet responsiveness to sequential thrombopoietin receptor agonists (TPO-RA) administration in chronic immune thrombocytopenic purpura (ITP)
Aleil B. - The relative contribution of the CYP2C19∗2 polymorphism in the low responsiveness to clopidogrel in the VASP02 study
Alekseeva L.A. - Urine fibrinolytic activity in elderly patients with hypertension
Aleksic D. - Importance of lifelong oral anticoagulant therapy in adolescent with congenital thrombophillia
Alemany G.V. - Survey on physicians’ adherence to deep venous thrombosis prophylaxis guidelines in a tertiary hospital
Alesci S. - Does therapy of hemophilia change in the elderly?
Alesci S.R. - Monitoring of different von Willebrand parameters after administration of vWF/FVIII-concentrates
Alesci S. - Prospective criteria for side effects of DDAVP
  - Periodontal treatment in a patient with aggressive periodontitis and von Willebrand disease: a case report
Alessandrello Liotta A. - Assessment of quality control and accuracy of portable coagulometers for monitoring oral anticoagulant treatment in anticoagulation clinic
Alessandro-Gabazza C.N.D. - Normalization of cytokines in pulmonary hypertension in mice deficient in thrombin activatable fibrinolysis inhibitor
Alessi M. - Predictive ability of post treatment ADP-induced aggregation and VASP index on stent thrombosis after acute coronary syndrome in clopidogrel-treated patients: a prospective study
Alessi M.C. - Reduced platelet inhibition in diabetic patients treated with clopidogrel is independently related to fibrinogen level but not to glycemic control
Alessi M. - Impact of the CYP2C19∗17 allele on platelet response to clopidogrel in patients suffering from non–ST elevation acute coronary syndrome
  - A multi-stage/multi-design strategy identifies a new QTL for von Willebrand factor on chromosome 6 – a possible link with VTE ?
  - Antithrombotic and antifibrinolytic effects of platelet protease nexin-1
Alessi M.C. - In PT G20210A carriers the genetic mutation and the history of venous thrombosis contribute both to thrombin generation independently of FII plasma levels
Alessi M. - Regulation of mouse embryonic stem cell commitment into the endothelial lineage by p38 mitogen-activated protein kinase
  - Common susceptibility allele are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach
  - CD11B-positive microparticles are an independent predictor of cardiovascular events in patients with coronary artery disease
Alessio A.M. - Circulating endothelial cells in deep venous thrombosis
Alexander R.A. - VEGF- induced initial endothelial cell migration requires urokinase receptor for integrin redistribution
Alexandrova E.N. - Thrombocytopenia in antiphosphoipid syndrome
  - Markers of inflammation and endothelial cells activation in patients with antiphospholipid syndrome depending on thrombosis localization
  - Analysis of lethal outcomes in patients with systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) based on long-term follow-up
Alexandru N. - Elevation of endothelial and platelet microparticles in patients with chronic venous insufficiency
  - Homocysteine induces changes in platelet calcium mobilization and function in type 2 diabetes mellitus
Alexanyan M.G. - Clinical efficacy and safety of high doses of Antithrombim III (AT) treatment of severe sepsis and septic shock in neutropenic thrombocytopenic patients (PTS)
  - Thrombin generation in patients (pts) with severe sepsis and septic shock during the treatment with high doses of antithrombin III (AT)
  - Ratio between time of XIIa-dependent fybrinolysis (FS) and antithrombin III (AT) activity as a marker of severity of sepsis
Alfahim A. - The avail me project: a first regional evaluation of venous thromboembolism (VTE) risk and prophylaxis practice
Alfter K. - Activation of fibrinolysis and bleeding history in patients with systemic mastocytosis
Algra A. - Activation of the intrinsic coagulation proteins and the risk of arterial thrombosis in young women
  - Antiphospholipid antibodies and the risk of myocardial infarction and ischemic stroke in young women
  - Genetic variation in coagulation factor XIII and the risk of arterial thrombosis: differences between myocardial infarction and ischaemic stroke
Alhenc-Gelas M. - Influence of the endothelial cell protein C receptor (EPCR) gene (PROCR) on protein C deficiency expression
  - Postmenopausal hormone replacement therapy: where do we stand?
  - The risk of heparin-induced thrombocytopenia is increased in patients homozygous for the GNB3 825T allele
Ali F.Y. - Making anti-thrombotic bypass vessels from selected populations of vascular smooth muscle cells
Ali U. - Systemic primary fibrinolysis due to tissue plasminogen activator (TPA) producing metastatic breast cancer
Ali E. - Development of a clinical cut-point for a new automated D-dimer
  - Retrospective evaluation of an immunoturbidometric D-dimer assay as a stand-alone test to exclude venous thromboembolism
Ali F.Y. - The effect of hydrogen sulphide on platelet action
Ali E. - Fibrin monomer: does it help improve the sensitivity and specificity of the D-dimer assay for identification of venous thromboembolism?
Alía P. - Effects of apolipoprotein E C.471T > C and C.609C > T polymorphisms on lipid- lipoprotein plasma levels in dyslipidemic and/or ischemic patients
Al-Jafar H.A. - Determination of adamts-13 and vWF antigen and activity levels in patients with thrombotic thrombocytopenic purpura and other thrombocytopenic disorders in kuwait
Alkindi S. - Genetic determinants of response to warfarin in omani patients
Allard S. - Acute traumatic coagulopathy is dependent on both injury severity and shock: clinical and experimental validation
  - Acute traumatic coagulopathy: functional characterisation by rotational thrombolelastometry
Allart S. - The new tyrosine-kinase inhibitor and anti-cancer drug dasatinib reversibly affects platelet activation in vitro and in vivo
  - A role for SHIP1 in platelet internal contraction via the control of actomyosin and microtubule dynamics
Allen K.L. - Modulation of KLF2 and KLF4 by antiphospholipid antibodies
Allen S. - Replacement of Phe992 and Phe993 with Ala in the integrin alphaIIb cytoplasmic motif changes the binding affinity to its interactors
Allen D.J. - Mitochondrial control of platelet apoptosis: role of the mitochondrial permeability transition pore
Alley S. - Endogenous thrombin potential as a novel method for characterisation of procoagulant snake venoms
Allievi A. - Susceptibility and clinical involvement of 4G/5G polymorphism of plasminogen activator inhibitor-1 (4G/5G PAI-1) gene in systemic lupus erythematosus (SLE). Preliminary results of a multicentre study
Allison A.C. - In vitro and in vivo antithrombotic effects of diannexin, a novel homodimer of annexin A5
Al-Marwani A.O. - Molecular genetic basis of inherited thrombocytopenia
Almasy L. - Pleiotropic effects in thrombotic-related traits using bivariate variance components models
  - Sex-specific genetic determination of fibrinogen plasma levels
  - Genetic variants underlaying fibrinogen levels: from linkage analysis to fine mapping on chromosome 12q24
  - Quantitative trait loci involved in the regulation of lipoprotein a (Lp(a)) levels: genome-wide linkage analysis from the gait project
  - Quantitative trait nucleotide analysis in the NNMT gene: a genetic determinant for homocystein levels
Almeida N. - Maternal tobacco smoke exposure in women with preeclampsia is associated with higher birthweight for gestational age
Almenar L. - Inflammation and coagulation markers in heart failure patients: transition from acute decompensated to chronic heart failure
  - High levels of circulating endothelial cells in heart failure
Almomen A.M. - Fondaparinox for a pregnant woman with deep vein thrombosis and heparin allergy
Almonte T.M. - Long-term bleeding history as a tool for hemophilia management
Aloisio L. - Management of kidney transplantation in a factor VII-deficient patient
Alonso S. - Paternal thrombophilia as a risk factor for deep vein thrombosis (DVT) during pregnancy and postpartum: influence of the paternal A3 haplotype of the EPCR gene on maternal DVT occurrence
  - In PT G20210A carriers the genetic mutation and the history of venous thrombosis contribute both to thrombin generation independently of FII plasma levels
Al-tamimi M. - Pathological shear rates increase levels of platelet receptor shedding
Altantsetseg E.E. - Platelets interaction with phospholipase A2 purified from the agkistrodon blomhoffii ussuriensis snake venom
Althaus H. - Quantification of prothrombin fragment 1+2 by LOCI¯ technology∗
Althaus K. - False positive tests for heparin induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus
  - Improving the capability of the anti-PF4/heparin enzyme immunosorbent assay to rule out platelet activating PF4/heparin antibodies
Altintas F. - Venous thromboembolism prophylaxis after major orthopedic surgery: a multi-center prospective observational study
Altisent C. - How can the right FVIII dosage to neutralise low titre inhibitor be calculated?
  - Minimally-invasive parathyroidectomy with recombinant activated FVII in GLANZMANN′S thrombasthenia
  - FVIII inhibitor epitope mapping in haemophilia A patients
  - Primary prophylaxis with recombinant factor VIIa (rFVIIa) in eleven haemophilia a patients with inhibitors younger than 3 years old
  - Continuous infusion practice in 22 haemophilia comprehensive care centres in 16 European countries
  - Evaluation of secondary prophylaxis with rfviia in hemophiliac patients with inhibitors
  - Sporadic versus familiar severe haemophilia A ratio in a neonate cohort
  - Haemostatic factor profile during orthopaedic replacement surgery in a healthy population
  - Redistribution of recombinant activated factor VII into platelets and the vascular bed: implications on hemostatic mechanisms
Altomare M. - Effects of childhood obesity on endothelial dysfunction and coagulative activation in obese children and adolescents
Altun M. - The comprehensive, multidisciplinary team for the treatment of haemophilia: istanbul experience
Alvarez M. - Haemophilia A in female patients
  - Anti-CD20 as alternative to splenectomy in patients with refractory immune thrombocytopenic purpura. Two years follow-up
  - Effect of soluble CD40L on the activity of matrixmetalloproteinase 9 of MEG-01 cells
  - Thrombelastography rotational (ROTEM¯) utility for monitoring patients with haemophilia and factor VIII inhibitors treated with FEIBA¯
  - Thrombelastography rotational (ROTEM¯) utility for monitoring patients with haemophilia and factor VIII inhibitors treated with rFVIIa (NOVOSEVEN¯)
  - Thrombelastography rotational (ROTEM¯) utility for monitoring treatment in a patient with acquired haemophilia
  - Rescue immunotolerance in haemophiliac patients to a serious with a high
Alvarez C. - Efficacy and safety of long term administration of bemiparin in patients who need cronic anticoagulation and have suffered severe and recurrent gastrointestinal bleeding
Al-Wazzan H.J. - Determination of adamts-13 and vWF antigen and activity levels in patients with thrombotic thrombocytopenic purpura and other thrombocytopenic disorders in kuwait
Aly Aldeen Abd Elbasset Aly Mohamed M. - Higher endogenous thrombin potential value as prothrombotic marker in newly diagnosed pediatric cancer patients
AlZadjali S. - Genetic determinants of response to warfarin in omani patients
Al-Zahrani F.M. - Oestrogenic and androgenic modulation of ITGA2 promoter activity and integrin alpha 2 expression level
Al-Zahrani A. - Equivalency of Tinzaparin and Enoxaparin children: a single centre report on efficacy and safety
Amadio P. - Inflammatory cytokines present in smokers’ serum modulate cyclooxygenase-2 expression via NADPH-oxidase in endothelial cells
Amanat S.T. - vWF:Ag and FVIII levels in the patients with von Willebrand disease: a single center study
Amann-Vesti B. - How should we treat afibrinogenaemia patients with thrombotic complications
Amano K. - The severity of bleeding symptoms in factor V deficiency caused by a novel compound heterozygous mutation (P1618R and IVS7 + 5 G > C)
  - The Japanese guideline for the hemostatic therapy of patients with congenital hemophilia and inhibitors
  - The Japanese guideline for the practical replacement therapy for acute bleeding and surgical prophylaxis in hemophilia without inhibitors
Amaral J. - Coagulation laboratory screening is not a good predictor for bleeding complications in pediatric patients requiring peripherally inserted central catheters
Amato A. - D-Dimer (DD) levels at diagnosis in relation to the site and extension of leg deep vein thrombosis (DVT)
  - Thrombophilic risk factors and peripheral arterial disease severity
Amaya M. - Platelet activation and thrombosis by anti-cd40l immune complexes
  - A prospective analysis of plasma tissue factor in patients with ovarian tumors
Amelot A.A. - Platelet factor 4 (CXCL4) shields plasma factor V to thrombin and retards activation
Amengual O. - Predictive value of the antiphospholipid score (aPL-S) for thrombotic events in patients with autoimmune diseases
  - The p38 mitogen-activate protein kinase (MAPK) pathway mediates the induction of tissue factor and adhesion molecule expressions on endothelial cells
Amico E.A.D. - Thrombocytosis associated with inflammatory disease: a risk factor for thromboembolic disease?
  - Intramural ureteral hemorrhage associated with contralateral iliopsoas hematoma in a patient with hemophilia a with inhibitor: case report
Amin A.N. - Appropriate VTE prophylaxis, compared with partial VTE prophylaxis, leads to lower VTE recurrence and cost in US medical patients
Amin C. - Thrombin generation and fibrin clot formation in patients with sickle cell disease (SCD)
  - Activation of coagulation in sickle cell trait; possible role for circulating microparticle tissue factor
Amin A.N. - Venous thromboembolism pharmacy intervention management program
Amirabadi A. - Functional MRI techniques as early diagnostic markers in hemophilic arthropathy
Amiral J.J. - New assays for measuring direct thrombin inhibitors on plasma
  - Pseudo-hit associated with antibodies to protamine sulfate
  - Can we improve clinical specifity for hit immunoassays?
Amiral J. - Suitability of chromogenic anti-Factor Xa methods to measure rivaroxaban in human plasma
Amirizadeh N. - In vitro properties of blood bank produced fibrin sealants from single donor human plasma
Amirkhosravi A. - A prospective analysis of plasma tissue factor in patients with ovarian tumors
  - Tumor cell-derived microparticles: does size matter?
  - Platelet activation and thrombosis by anti-cd40l immune complexes
  - Detection of tissue factor activity in whole blood by a fluorogenic thrombin generation assay
  - Role of tissue factor (TF) in leukemia-associated coagulation activation and VEGF expression
  - Platelet surface binding enhances immune complex-induced platelet aggregation
Amlie-Lefond C. - Concurrent PAS and CSVT in the newborn
Ammollo C.T. - In vivo tafi activation in off-pump coronary artery bypass surgery (OPCAB): effect of different heparin dosages and correlation with thrombin and plasmin generation
  - TAFI-dependent inhibition of fibrinolysis by platelets evaluated in whole blood by thromboelastography
  - The novel direct thrombin inhibitor dabigatran accelerates plasma fibrinolysis through tafi-dependent and -independent mechanisms
  - Enhancement of clot lysis by anticoagulants: dabigatran is more equal than heparin
Amodeo R. - A prospective study about von Willebrand diasese in women with obstetric and gynaecological problems
  - Monozygotic twins monocorial childbirth in a primipara patient suffering from von Willebrand disease. follow up during pregnancy and prophylaxis of surgical caesarean
Amore C. - Glycogen synthase kinase-3 negatively regulates tissue factor gene expression in monocytes interacting with activated platelets. a novel mechanism linking thrombotic risk and metabolic disorders
Amuzescu M. - Elevation of endothelial and platelet microparticles in patients with chronic venous insufficiency
Anak S. - Plasma levels of plasminogen activator inhibitor type 1 and vitronectin in children with solid tumors
Anand S.S. - Dose-dependent effects of aspirin on platelet function
Anand S. - Urine 11dehydro-thromboxaneB2 concentrations are higher post CABG compared with healthy controls
Anastasopoulou I. - Monitoring of low molecular weight heparin (LMWH) therapy by anti-Xa assay. a laboratory perspective using heparin specific standards
  - Sequential therapy with rFVIIa and activated prothrombin complex concentrates (aPCCs) in haemophilia B patient with inhibitor and life threatening bleeding
  - Follow up of TTP patients and results of splenectomy in relapsing cases. experience of one centre
Anastasovska L. - Patients treated with oral anticoagulant therapy and dental extraction
Anastasovski S. - Patients treated with oral anticoagulant therapy and dental extraction
Ancona E. - Whole blood thromboelastometry in human and cynomolgus monkeys
and the PROTECHT Study Group  - Hemostatic variables in cancer patients receiving low-molecular-weight heparin (LMWH) nadroparin or placebo during chemotherapy in the protecht trial
and the RIETE Investigators  - Comparison of the clinical history of symptomatic isolated distal deep-vein thrombosis versus proximal deep-vein thrombosis in 11 086 patients: results from the RIETE registry
Ande A.B. - Haemostatic profile and determinants of rheology in nigerian pre-eclamptics
Ande A.A. - Reduced fibrinolysis in women after delivery
Andersen M. - Stored platelet pools lose their ability to facilitate aggregation but maintain their support of clot formation as evaluated in a model of whole blood thrombocytopenia
Andersen A.S. - Urinary prothrombin fragment 1.2 (uF1.2) levels in pregnancies complicated by preeclampsia
Andersen M.D. - Prolonged In Vivo half-life and retained activity of factor IX glycopegylated in the activation peptide
Andersen M.R. - Gestation age specific reference intervals for coagulation tests during uncomplicated pregnancy delivery and early postpartum period
Andersen M. - A case of severe inherited hyperhomocysteinemia in a young male having venous thromboembolism and claudication successfully treated with vitamin B6 and B9
Anderson D. - Feasibility of recruitment and retention in an unblinded randomized controlled trial of exercise training for the post-thrombotic syndrome
Anderson F.A. - Bleeding concerns drive practices of orthopedic surgeons in prevention of venous thromboembolism in primary hip and knee arthroplasty
  - Practices in prevention of venous thromboembolism in primary hip and knee arthroplasty vary with surgeon operative volume: findings from a survey of US orthopedic surgeons
Anderson P.J. - Unproductive binding of ADAMTS13 to von Willebrand factor
Anderson F.A. - Venous thromboembolism risk factors in acutely ill hospitalized medical patients: findings from the improve registry
Anderson F. - Impact of age, body mass index, and renal impairment on venous thromboembolism risk and prophylaxis practices in the acute hospital care setting: a subanalysis of the endorse survey
Anderson D.A. - Validation of a diagnostic approach to exclude recurrent venous thromboembolism
Andersson A. - Anionic phospholipids lose their procoagulant properties when incorporated into high-density lipoproteins
Andersson H.M. - Activated protein C cofactor function of protein S: a critical role for the EGF1-like domain
Andjelkovic N. - Should we screen coagulation in women with menorrhagia?
Andrade M.V. - Permissive hypotension and desmopressin enhance clot formation
Andre S. - Role of the spleen in the initiation of the immune response to therapeutic factor VIII in hemophilia A
Andre P. - Pharmacological uncoupling of arterial thrombosis from hemostasis
  - Clopidogrel and prasugrel prolong primary hemostasis in the mouse beyond levels associated with P2Y12 inhibition
  - A functional pool of P2Y12 receptors exposed upon platelet activation persists in mice treated with high dose clopidogrel, and can be blocked by elinogrel, a direct acting, reversible P2Y12 inhibitor
  - ADP-mediated aggregation as a pharmacodynamic assay underestimates the antithrombotic activity of elinogrel, a competitive, reversible P2Y12 inhibitor, relative to clopidogrel
  - The antiplatelet effect of a new, direct acting, reversible P2Y12 inhibitor, elinogrel (PRT060128) in patients with high platelet reactivity during clopidogrel therapy
André S. - Multiplexed analysis of immunoglobulin class/subclass and epitope specificity of anti-FVIII antibodies in six cases of postpartum acquired hemophilia
  - Reduction of the anti-factor VIII humoral immune response in factor VIII-deficient mice following materno-fetal transfer of anti-factor VIII IgG
  - Accumulation of therapeutic factor VIII in the marginal zone of the spleen of factor VIII-deficient mice
Andrea D. - Release of pentraxin-3 from activated neutrophil modulates platelet-neutrophil cross-talk
Andrei E. - Elevation of endothelial and platelet microparticles in patients with chronic venous insufficiency
Andrei-Selmer C. - PECAM-1 polymorphism in Ig domain 6 (S536N) plays a role in transendothelial migration of neutrophils
Andreozzi G. - Age is more important to predict carotid stenosis amenable of surgical correction than focal neurological symptoms
Andrew P.C. - Proteomics of human microparticles after deep venous thrombosis
Andrews R.K. - Pathological shear rates increase levels of platelet receptor shedding
Andrews R. - Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function
Andrews R.K. - TRAF4 (TNF-receptor associated factor 4): a novel link between glycoprotein Ib and glycoprotein VI and redox-dependent signaling pathways in human platelets
  - Sequence differences in the N-terminal region of mouse GPIbalpha change protease specificity and prevent thrombin binding
Andronicos N.M. - plg-RKT, a novel, structurally unique, and developmentally regulated transmembrane receptor for plasminogen
Andziak P. - Influence of public awareness about DVT symptoms and burden on the rate of confirmed DVT events
Angela D. - Low risk for symptomatic venous thromboembolic events (VTE) during cytokine administration for peripheral blood stem cell mobilization
Angelillo A. - Canadian platelet-type von Willebrand disease (PT-VWD) project: progress and update
Angelillo-Scherrer A. - Generation and phenotypic analysis of protein s-deficient mice
  - Human Gas6 contributes to late integrin alphaIIbbeta3 activation and thrombus stabilization: involvement of Akt
  - Novel role for connexin37 in FVIII secretion and coagulation
Angeloni G. - Platelet activation and platelet-leukocyte mixed conjugates in patients with atrial fibrillation
Angelosanto N. - Protein C deficiency and risk of thrombosis
Angerer J.I. - Von Willebrand factor self-assembly under elevated shear stress fosters activation-independent platelet string formation
  - Membrane elasticity and cytoskeletal structure determine platelet tether and microparticle formation under shear stress
  - Importance of multimer size for von Willebrand factor function under blood flow – comparison of commercially available products
Angio-Getbo Group A. - Diagnosis of deep vein thrombosis by compression ultrasonography during pregnancy and the postpartum period: a management outcome study
Angiolillo D.J. - Effects of the 5-HT4 receptor agonist, tegaserod, on in vitro human platelet aggregation
Angles-Cano E. - Lipoprotein (a) as a predictor of further clinical events in patients with coronary disease
  - Endothelial microparticles plasmin generation: a new mechanism regulating endothelium proteolytic activities
  - In vivo and in vitro profibrinolytic effect of MMP-10 mediated by TAFI: a new role for MMPs on fibrinolysis?
  - Fibrinolytic crosss-talk: platelet-bound plasminogen is activated by monocyte uPA
Anglés-Cano E. - Plasmin formation on neurons stimulates the release of neuron-derived microparticles bearing proteolytic activity
Angus G. - O-linked glycosylation of VWF is an important modulator of ADAMTS13 proteolysis and binding to GPIb
Anicchino-Bizzacchi J.M. - Lower incidence of IgGs subclasses of anti-FVIII antibodies that recognize an intermediate-purity plasma derived factor VIII product in severe hemophilia A inhibitor positive patients
Anisimov M.G. - Role of congenital thrombophilic conditions in the development of thrombus flotation
Ankri A. - Performance of the HemosIL Thrombopath assay in the screening for protein C pathway abnormalities. preliminary results in 352 unselected patients with a history of thrombosis
Annarumma L. - Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population
  - Association of endogenous thrombin potential (ETP) with coronary artery disease. an angiography-based study
Annetta S.E. - Antiphospholipid syndrome (APS) in a pediatric cohort with venous thromboembolism
  - Lupus anticoagulant hypoprothrombinemia syndrome (LAHPS) and antiphospholipid antibodies: report of four children with long term follow-up
Annichino-Bizzacchi J.M. - Maximal aggregation or slope: which one should be used in platelet aggregation reports?
  - Circulating endothelial cells in deep venous thrombosis
  - Analysis of the genetic expression of inflammatory mediators from deep venous thrombosis patients
  - Analysis of the genetic expression from acute deep venous thrombosis
  - Allelic variants of human factor VIII in brazilian patients with severe hemophilia A and correlation with the risk of inhibitor
  - Molecular changes in vWF and ADAMTS13 genes and their correlation with plasma levels of FVIII and vWF in patients with deep venous thrombosis
  - Increased activity of coagulation factors FVII and fix associated with recurrent thrombosis
  - The factor VIII D1241E polymorphism, levels of factor VIII and risk of deep venous thrombosis in a brazilian population
  - Performance of a portable monitor of prothrombin time in a university anticoagulation clinic in Brazil
  - Encapsulation of heparin in polymeric nanopaticles
  - Screening laboratory Brazilian program of haemophilia and inhibitors
  - Rare VKORC1 mutations in African Brazilian patients taking oral anticoagulant therapy
  - Determination of ristocetin cofactor activity: eyes on both directions
  - Prospective evaluation of safety and eficay of radiosynoviorthesis with hydroxyapatite-yttrium in chronic synovitis in hemophilia: preliminary results
  - Hemostasis in patients submitted to abdominoplasty with and without previous history of reduction gastroplasty
Annichino-Bizzachi J.M. - Spontaneous cervical epidural haematoma in haemophilia: an important differential diagnosis of unspecific back pain
Annie Bang K.W. - Do young platelets have an enhanced capacity to expose procoagulant phosphatidylserine (PS) upon activation?
Ansell S.M. - Low risk for symptomatic venous thromboembolic events (VTE) during cytokine administration for peripheral blood stem cell mobilization
Antalfi B. - Factor XIII a subunit Val34Leu polymorphism in patients surviving or not surviving ischemic stroke
Antic D.A. - Successful treatment of intracranial haemorrhage in two patients with haemophilia A and inhibitors
Antic D. - Acquired von Willebrand syndrome in patients with multiple myeloma
Antman E. - The relationship between oral factor Xa (FXa) inhibitor du-176b pharmacokinetics (PK) and the probability of bleeding events (BE) in patients with atrial fibrillation (AF)
Antmen B. - The value of early treatment in patients with haemophilia and inhibitors
  - Successful use of activated recombinant factor VII in the cerebral operation for intracerebral hemorrhage in a patient with factor VII deficiency
  - Inguinal hernia operation and circumcision in a hemophilia a patient with inhibitor
Antoine G. - Towards a new hemophilic mouse model for the detection of neo-antigen formation in human factor VIII
Anton A. - Pharmacogenetic relevance of CYP4F2 V433M polymorphism on acenocoumarol therapy
Antón A.I. - Functional consequences of the prothrombotic serpinc1 rs2227589 polymorphism on antithrombin levels
Antón A. - Molecular and functional characterization of novel mutations in GPIX and BETA3 integrin giving rise to Bernard-Soulier syndrome and to an atypical glanzmann's thrombasthenia-like syndrome in two patients misdiagnosed with idiopathic thrombocytopenic purpu
Antón A.I. - Assessment of genotype-phenotype relationship for six common platelet polymorphisms in 286 healthy subjects
Antón A. - Role of 18 functional hemostatic polymorphisms in mucocutaneous bleeding
  - Calu A29809G polymorphism role in coronary atherothrombotic plaques and prognostic involvement
Antón A.I. - First type II antithrombin deficiency caused by a large insertion. structural and functional relevance
  - The common and functional F12 -4 c>t polymorphism coupled with low FXII levels significantly associated with reduced FVIIc and FIXc levels, prolonged aPTT, and less thrombin generation
Antonazzo P. - Fetal and maternal thrombophilia in iugr with or without maternal hypertensive disease
Antongiovanni M. - Effect of a diary product (pecorino cheese) naturally rich in CIS-9, TRANS-11 conjugated linoleic acid on lipid, inflammatory and haemorheological variables: an intervention study
Antoni G. - A multi-stage/multi-design strategy identifies a new QTL for von Willebrand factor on chromosome 6 – a possible link with VTE ?
Antonijevic N. - Localisation and period of venous thrombosis occurrence in thrombophilic women with pregnancy and puerperium related venous thromboembolic disease
Antonijevic N.M. - Prothrombotic tendency in patients with hyperthyroidism
Antonijevic N. - Prothrombotic genetic risk factors in stroke: a possible different role in pediatric and adult patients
Antonijoan R.M. - Pharmacokinetics and safety of bemiparin after multiple prophylactic and single therapeutic doses in young and elderly healthy volunteers – no need for dose adjustment
  - Pharmacokinetics and safety of a novel ultra low molecular weight heparin (RO-14) in healthy volunteers – a first time in human (FTIH) single ascending dose study
Antonino M. - Dark chocolate effect on platelet activity, C-reactive protein and lipid profile: a pilot study
  - The relation between platelet reactivity and HBA1c in diabetic patients with cardiovascular disease on maintenance aspirin and clopidogrel therapy
Antonino M.J. - Platelet reactivity to adenosine diphosphate and long-term ischemic event
  - Platelet function in patients undergoing aorto-coronary artery bypass surgery
Antonino M. - Cytochrome P450 2C19 genotype is a major determinant of clopidogrel response and a predictor of post-stenting ischemic event occurrence
  - The antiplatelet effect of a new, direct acting, reversible P2Y12 inhibitor, elinogrel (PRT060128) in patients with high platelet reactivity during clopidogrel therapy
Antonino M.J. - The antiplatelet response to clopidogrel in diabetic patients undergoing elective coronary stenting
  - Aspirin responsiveness measured by COX-1 specific and COX-1 non-specific methods in healthy subjects: clarifying the debate on aspirin ‘resistance’
  - Effect of eptifibatide added to bivalirudin on periprocedural inflammation and platelet function in elective stenting
  - Effect of long-term clopidogrel treatment on platelet function and inflammation in patients undergoing coronary arterial stenting
Antonino M. - Platelet reactivity in different ethnicities and gender (Pride G) pilot trial
Antonino M.J. - Antiplatelet effects of aspirin with phytosterols: comparison with non-enteric coated aspirin alone
Antonova O.A. - Activation and injury of cultured endothelial cells in hypoxia and reoxygenation. Effects of extracellular pH
Antonucci E. - Platelet reactivity in stable atherosclerotic disease patients on chronic antiplatelet treatment
  - Monitoring platelet function in coronary heart disease patients on clopidogrel therapy: whole blood multiplate impedance aggregometer compared to classical and new platelet function methods
  - Reticulated platelets and platelet reactivity in renal trasplant recipients on antiplatelet therapy
  - Transthoracic echocardiography in patients with a first episode of pulmonary embolism (PE) for the detection of chronic thromboembolic pulmonary hypertension (CTPH)
  - Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients are predicted by residual platelet reactivity to ADP in the absence of CYP2C19∗2 allele: beyond genetic screening
  - Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment
  - Stroke risk in atrial fibrillation patients on warfarin: predictive ability of risk stratification schemes for primary and secondary prevention
  - Bleeding risk during oral anticoagulation in atrial fibrillation patients older than 80 years
  - Relevant risk of bleeding in atrial fibrillation patients on warfarin waiting for elective cardioversion
  - Hyperhomocysteinemia and risk of venous thromboembolism recurrence after a first episode of pulmonary embolism
  - Obesity as a possible risk factor for incomplete restoration of pulmonary perfusion after pulmonary embolism (PE)
  - Effect on light transmittance aggregation of adjustment of platelet count in platelet-rich plasma in patients on dual antiplatelet therapy
  - Platelet aggregation in whole blood: sodium citrate or hirudin as anticoagulant?
  - Comparison of whole blood multiplate impedance aggregometry with platelet function tests to assess residual platelet reactivity
  - Platelet function assessment by multiple electrode whole blood aggregometry in high risk patients with coronary artery disease on antiplatelet therapy
  - Close monitoring of hemostasis by thromboelastometry during extracorporeal membrane oxygenation (ECMO)
  - Assessment of quality control and accuracy of portable coagulometers for monitoring oral anticoagulant treatment in anticoagulation clinic
  - Low-dose aspirin therapy after kidney transplantation
Antovic J. - Should we screen coagulation in women with menorrhagia?
Antovic A. - Glycemic control is of major importance for fibrin clot structure in type 1 diabetes
  - Effects of atorvastatin on haemostasis in patients with type 1 diabetes
Antovic J. - Factor XI deficiency in animal models
Antovic J.P. - Evaluation of the endogenous thrombin potential (ETP) assay
Antovic A. - Reduced expression of tissue factor on platelet derived microparticles during atorvastatin treatment in patients with peripheral artery disease
Antovic J. - A multicolor flow cytometric assay for the detection of platelet derived microparticles
Antovic J.P. - Comparison of immunological assays for detection of heparin/PF4 antibodies in hit patients
Antovic A. - Changes in von Willebrand factor and ADAMTS-13 during in vitro fertilization
Antovic J. - Differential effect of prophylactic or on demand treatment regimes in hemophilia A patients on TAFI activation
Antunes M.B. - Prophylatic treatment of haemophilia A patients with inhibitors
Anveden P. - Bedside point of care coagulation testing for individualized antivitamin K reversal in emergency surgery
  - Can Proteins Induced by Vitamin K absence – PIVKA II – detect subclinical vitamin K deficit in major surgery?
Anyanwu R.A. - Haemostatic profile and determinants of rheology in nigerian pre-eclamptics
Aoki S. - Direct effects of protein S in ameliorating acute lung injury
  - Normalization of cytokines in pulmonary hypertension in mice deficient in thrombin activatable fibrinolysis inhibitor
Aouba A. - Successful neurosurgery of a malignant glioneuronal tumor (MGT) under recombinant activated factor VII (rFVIIa) cover in a severe hemophilia a patient with a high titer inhibitor (SHHI)
Aoun J. - The avail me project: a first regional evaluation of venous thromboembolism (VTE) risk and prophylaxis practice
Apan H. - Selection of a fluorogenic marker for use in whole blood (WB) enzymatic assays
Apeler H. - Binding to activated platelets and enhanced clotting properties of the recombinant FVIIa analogue Bay7
Apergis G. - Retinal vein thrombosis (RVO) and thrombophilia
Apitz-Castro R. - Thrombin generation in a thin layer of whole blood
Apostolovska R. - The management of elevated APL in pregnancy
  - Anti beta 2 glycoprotein I antibodies at women with pathological pregnancy
  - Evaluation of arterial thrombosis at female
  - Patients treated with oral anticoagulant therapy and dental extraction
  - Laboratory monitoring of heparinemy
Appa R. - Elimination of human recombinant mammalian tissue factor pathway inhibitor in a rat model
  - Unfractionated heparin promotes elimination of human recombinant mammalian TFPI in a rat model
Appa R.S. - Clearance of activated recombinant human coagulation factor VII (rFVIIa) in rat and mouse liver
  - Reabsorption of recombinant activated VII (rFVIIa) in renal proximal tubules of the kidney in rodent models
Appa R. - Clearance of recombinant and plasma derived human factor VIII in a perfused rat liver model
  - Investigation of clearance of recombinant human factor VIIA and its variants in a perfused rat liver model
Appel B. - Antibodies of patients with heparin-induced thrombocytopenia recognize complexes formed by platelet factor 4 and nucleic acids
Appelbom H.I. - Pivotal role of tissue factor pathway inhibitor (TFPI) for local regulation of tissue factor (TF) – induced thrombin generation in monocytes isolated from human blood
Appio L. - JAK2V617F mutation for the early diagnosis of Ph-myeloproliferative neoplasms in patients with venous thromboembolism. a meta-analysis
  - JAK2V617F mutation in patients with arterial thrombosis in the absence of overt myeloproliferative disease
Arachiche A. - Rapid procoagulant phosphatidylserine exposure relies on high cytosolic calcium rather than on mitochondrial depolarization
Aranko K. - Effect of blood clots on the megakaryocytic potential of thawed cord blood units
Arantes M.J. - Activated protein C cofactor function of protein S: a critical role for the EGF1-like domain
Araujo G. - Homocysteine plasma levels and MTHFR C677T mutation
Araújo I.G. - Effects of oversulfated and fucosylated chondroitin sulfates on coagulation. Challenges in studies of anticoagulant polysaccharides
Araya V. - Increased levels of circulating endothelial cells in patients with major depression
Arbasi M. - Inherited bleeding disorders: the emilia romagna region registry, 2008 update
Arbesú I. - Genetic variants underlaying fibrinogen levels: from linkage analysis to fine mapping on chromosome 12q24
  - Sex-specific genetic determination of fibrinogen plasma levels
Arbuthnot C. - Prevent – an electronic VTE risk assessment tool and decision support in acute inpatients
Arca M. - Genetic regulation of inflammation-mediated haemostasis activation: a family-based approach
Arcaini L. - Platelet volume, platelet diameter and thrombopoietin level for differentiating inherited thrombocytopenias from idiopathic thrombocytopenic purpura
Arcamone G. - Protein C replacement during febrile neutropenia in pediatric patients with cancer
  - Magnetic resonance imaging: is it useful for diagnosis of asymptomatic cerebral thromboembolic events in children with acute lymphoblastic leukaemia?
Arcangeli C. - Transthoracic echocardiography in patients with a first episode of pulmonary embolism (PE) for the detection of chronic thromboembolic pulmonary hypertension (CTPH)
  - Obesity as a possible risk factor for incomplete restoration of pulmonary perfusion after pulmonary embolism (PE)
  - Hyperhomocysteinemia and risk of venous thromboembolism recurrence after a first episode of pulmonary embolism
Arcari A. - Pulmonary function, C-reactive protein and cardiovascular risk in the moli-sani population
Arcelus J. - Evaluation of duration of thromboembolic prophylaxis after major orthopedic surgery: the ETHOS registry
Archarit N. - Impaired responsiveness of platelets to adrenaline is an insignificant laboratory finding for women with menorrhagia
Arderiu G. - Tissue factor promotes and stabilizes the vascular phenotype of newly form capillaries
  - Tissue factor localizes in the leading edge of migrating human vascular smooth muscle cells and its down-regulation significantly reduces migration
Ardeshiri Y. - Frequency of intracranial hemorrhage among iranian patients with rare bleeding disorders
  - Frequency of menorrhagia among Iranian women with rare bleeding disorders
Ardissino D. - Increased active von Willebrand Factor in young women with acute myocardial infarction
Arellano A.R. - Single nucleotide polymorphisms in AKT3 are associated with deep vein thrombosis
Arepally G.M. - Heparin-induced thrombocytopenia: insights from murine models
Arepally G. - Heparin antibody complexes activate monocytes and induce the release of tissue factor positive microparticles
Arguello A. - The application of thromboelastgraphy (TEG) in the study of haemostatic disorders
  - Multidisciplinary approach for optimization of haemophilia care in Venezuela
Arguello S. - Recombinant activated factor VII prophylactic treatment for intracranial hemorrhage in a hemophilia patient with inhibitors
Arguello A. - Rotational thromboelastography (ROTEM) as a tool for assesing the clinical response to hemostatic agents in bleeding disorders
Arhan M. - Topical ankaferd blood stopper administration to bleeding gastrointestinal carcinomas can control local hemorrhage and decrease tumor vascularization
Arias-Salgado E. - Effect of soluble CD40L on the activity of matrixmetalloproteinase 9 of MEG-01 cells
Aridogan A. - Inguinal hernia operation and circumcision in a hemophilia a patient with inhibitor
Ariens R.A.S. - Clotting factors, inflammatory markers and glycemic control in diabetes: role in clot structure and fibrinolysis
  - Fibrinogen Birmingham II – a novel variant associated with hypodysfibrinogenemia, due to compound heterozygosity for Trp334Cys and Asn335Tyr in the fibrinogen A alpha chain
  - Ala312Thr polymorphism is not associated with changes in clot structure in a recombinant system: pitfalls in analyzing plasma-purified protein
  - Insights into the mechanism underlying polyphosphate stimulated autoactivation of factor XII
  - Polyphosphate modifies fibrin structure and increases the resistance of clots to fibrinolysis
  - The role of the fibrinogen alpha chain in enhancing FXIII activation
Ariëns R.A.S. - The role of barrels 1 and 2 in enzymatic activity of factor XIIIa
  - The influence of alpha-2-antiplasmin polymorphism Arg6Trp on fibrinolysis; the leeds family study
  - The effect of blood coagulation factor XIII on fibrin clot structure and function
  - Analysis of fibrin structure and function in man exposed to transient diesel exhaust
Ariens S. R.A. - Aspirin and cardiovascular disease: a cyclooxygenase-independent mode of action
Arif A. - Post-transcriptional regulation of inflammatory gene expression
Ariga T. - Urokinase-type plasminogen activator induces hepatic differentiation of embryonic stem cell.
Arikan E. - Is there any effect of obesity on thrombin activatable fibrinolysis inhibitor levels in postmenopausal women?
Arina G.A. - Quality of life of inhibitor patients in Russia
Aristizabal M. - Inhibitors in children during secondary prophylaxis for hemophilia in a developing country
Armand-Perroux A. - Effect of a computerized handheld clinical decision support system on the appropriateness of pulmonary embolism diagnosis in emergency departments. a cluster controlled clinical trial
Armani C. - Role of the renin angiotensin system in the modulation of tissue factor expression by TNF-alpha-stimulated human umbilical vein endothelial cells
Armero S. - Tailored clopidogrel loading dose according to platelet reactivity monitoring to prevent acute and subacute stent thrombosis
Armini A.M.D. - The pavia endarterectomy program for the management of pulmonary endarterectomy (PEA) in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Armstrong P.C.J. - Determination and differentiation of aspirin and clopidogrel effectiveness by 96-well plate aggregometry and measurement of thrombi adhesion
  - Urinary 11-dehydro-thromboxane B2 as a marker of the anti-platelet effects of clopidogrel or aspirin therapy in healthy male volunteers
  - The effect of hydrogen sulphide on platelet action
  - Nitric oxide inhibits platelet aggregation independantly from formation of thromboxane A2
Arnason J.E. - Peri- and post-operative hematologic management in a patient with type II von Willebrand disease undergoing mitral valve replacement
Arnaud E. - Selection of a fluorogenic marker for use in whole blood (WB) enzymatic assays
  - Influence of a fluorogenic substrate on thrombin generation: when in silico simulations predict in vitro experiments
  - New assay for quantifying functional domain-specific inhibitors against human VWF in plasma
  - Sensitivity of 2 functional haemostasis assays to platelet-derived microparticles (PMP)
Arnaud P. - The french blood products supply database (MDSRAppro): an effective tool for long-term national surveillance of coagulation factors and management of supply shortages a coordination between pharmacists, physicians, patients association, health authoriti
Arnaud E. - The use of polybrene for heparin neutralisation in the thrombin generation test
Arnaud L. - Impact of immunosuppressive treatment on endothelial biomarkers after kidney transplantation
Arnaud E. - How to overcome the inner filter effect in fluorescent substrate activity assays?
Arndt B. - Quantitative interpretation of optical density measurements of IgG antibodies against Heparin/PF 4-complex in comparison with results of our functional assay – is there a better cutoff value?
Arnesen H. - Levels of von Willebrand Factor as measure of endothelial dysfunction are increased in elderly patients with atrial fibrillation
  - Prediction of cardiovascular events by MMP-9 in elderly men
  - The frequency and intra-individual variation of clopidogrel non-responsiveness over time as measured by VerifyNow in patients with stable coronary heart disease
  - Frequency and gender differences of polymorphisms in the TF and TFPI genes, as related to phenotypes in patients with coronary heart disease
  - Left ventricular (LV) thrombus formation in spite of intensive antiplatelet treatment in patients with acute anterior wall st-elevation myocardial infarction (STEMI) treated with PCI
Arning M. - A phase III, double-blind, placebo-controlled study (RAISE) of eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura (ITP)
Arnold M. - Factor XIII activation peptide and subunit antigen levels in patients with acute ischaemic stroke
Arnould B. - Convenience of and satisfaction with the new long-acting anticoagulant idraparinux (IDRA) vs. vitamin K antagonist (VKA) in patients with deep venous thrombosis (DVT), pulmonary embolism (PE) and atrial fibrillation (AF)
Arnout J. - Analytical performance of new and quantitative assays for the diagnosis of antiphospholipid syndrome on a fully automated, chemiluminescent analyzer
  - Clinical performance of new and quantitative assays for the diagnosis of antiphospholipid syndrome (APS) on a fully automated, chemiluminescent analyzer
  - New automated chemiluminescent VWF:Ag and VWF:RCo assays: preliminary analytical and clinical performance
  - New automated chemiluminescent d-dimer immunoassay: analytical and clinical performance in patients suspected of vte
  - Performance of a new turbidimetric D-Dimer assay adapted to automated coagulometers
  - New automated ristocetin cofactor activity assay to distinguish type 1 and type 2 von Willebrand Disease (VWD)
Arnuti B. - Management of pregnancies with high risk of thrombosis: a multicenter prospective study
Arocas V. - Protease nexin-1 is anti-angiogenic in vitro independently of its anti-protease activity
  - Antithrombotic and antifibrinolytic effects of platelet protease nexin-1
Aronis S. - Presumed perinatal ischaemic stroke
  - Efficacy and safety of a von Willebrand factor concentrate with a low FVIII content in children with von Willebrand disease (vwd)
  - Successful tolerization with high von Willebrand factor/factor VIII content ratio concentrate of children with severe haemophilia A and high responding inhibitor
Arora V. - Preclinical toxicology and safety pharmacology of plasmin (Human)
  - Dose response study of intra-arterial plasmin to recanalize the thrombo-occluded rabbit middle cerebral artery
Arora N. - Lupus anticoagulant – with hypoprothrombinaemia: a report of 2 cases
Arruda V.R. - Induction of immuno tolerance to canine FVIII (CFVIII) using liver directed, AAV mediated expression of CFVIII in hemophilia a dogs with inhibitor antibodies
Arruda V. - Evidence of the first X-linked thrombophilia due to a novel mutation in clotting factor IX gene resulting in hyperfunctional fix: factor IX arginine 338 leucine (factor IX padua)
Arruda V.R. - Zymogen-like factor Xa variants improve hemostasis in hemophilia mice
Arruda V. - Novel factor XA variants for improving hemostasis in hemophilia
Arshinov A.V. - The parameters of immune inflammation and haemostasis in patients with systemic lupus erythematosus (SLE) with antiphospholipid syndrome (APS) and without APS
Arslan A.A. - Association of anti-β2GPI domain I IgG and resistance to annexin A5 with obstetrical antiphospholipid syndrome: evidence for a specific mechanism in a patient subset
Arslan F. - eNOS Glu298Asp gene polymorphism in the cases of idiopathic thrombocytopenic purpura
Artesani L.L. - Outcome after central venous lines related venous thrombosis (CVL-VT) in children with acute lymphoblastic leukemia (ALL): a single centre prospective study
Arthur J.F. - TRAF4 (TNF-receptor associated factor 4): a novel link between glycoprotein Ib and glycoprotein VI and redox-dependent signaling pathways in human platelets
Artoni A. - Larger von Willebrand factor multimers play a role in generating platelet microparticles
  - Identification of two novel P2Y12 ADP receptor gene defects in patients with type 1 von Willebrand disease
  - Intraplatelet localization of ADAMTS13
Arya R. - Assessing the uptake of national initiatives to improve venous thromboembolism patient care in the UK
  - Thrombin generation is increased in post menopausal women using hormone replacement therapy administered by the oral but not the transdermal route
  - Peak thrombin generation correlates with estradiol levels in women who use hormone replacement therapy administered by the oral but not the transdermal route
Arza B. - Performance of a new turbidimetric D-Dimer assay adapted to automated coagulometers
Arzamendi D. - Anti-thrombotic effects of an anti-von Willebrand factor A1 domain aptamer in blood from patients under aspirin and clopidogrel therapy
  - Thrombin-activatable fibrinolysis inhibitor genetic polymorphisms as markers of the type of acute coronary syndrome
Asada Y. - Disturbed blood flow induces erosive injury of tissue factor-rich intima and promotes thrombus formation
  - Inhibition of factor XI reduces thrombus formation in rabbit jugular vein under conditions of endothelial denudation and/or blood stasis
  - Factor VIII contributes to platelet-fibrin thrombus formation via thrombin generation under low shear conditions
Asada R. - Re-exposure to heparin in uremic patients requiring hemodialyisis with heparin-induced thrombocytopenia
Asahara M. - Effects of l-asparaginase therapy on thrombin generation in children with acute leukemia
Asakura H. - Combined antiplatelet agents might help prevent arterial thromboses in antiphospholipid syndrome
  - Plasma levels of platelet-derived microparticles (PDMP) might comprise a useful indicator for antiplatelet therapy in antiphospholipid syndrome (APS)
Ashby D. - Air travel and risk of venous thromboembolism: a community-based study
Ashcroft B. - The detection of nanosized blood microparticles by atomic force microscopy
Ashikaga T. - Factor Xa generation in adult individuals
Ashrani A.A. - Is progesterone an independent risk factor for incident venous thromboembolism (VTE)? a population-based case-control study
  - Role of lipid lowering therapy (llt) on venous thromboembolism (vte) risk: a population-based case-control study
  - Systemic primary fibrinolysis due to tissue plasminogen activator (TPA) producing metastatic breast cancer
Asidin N. - VWF:CB and VWF:RCo. Assay to differentiate between type 1 and type 2 von Willebrand disease in national blood centre
Askalan R. - Extensive cerebral sinus venous thrombosis in the setting of hyperthyroidism in a child
Asmelash G. - Monitoring of different von Willebrand parameters after administration of vWF/FVIII-concentrates
  - Prospective criteria for side effects of DDAVP
  - Does therapy of hemophilia change in the elderly?
Asmis L. - Adequacy of venous thromboprophylaxis in acutely ill medical patients (impart): preliminary report of a multisite comparison of different decision support systems
Asmis L.M. - Differential expression and secretion of tissue factor and tissue factor pathway inhibitor modulate endothelial thromboresistance in vitro
Assafim M. - Bothrojaracin a prothrombin inhibitor with potent anti-thrombotic activity
Asselta R. - Mutational screening of 25 unrelated FV-deficient patients from six countries
  - Characterization of the genetic basis of FXI deficiency in fourteen unrelated patients
  - Mutations causing premature termination codons in the von Willebrand Factor gene are associated with allele-specific and position-dependent mRNA decay
  - Retrospective evaluation of dysfibrinogenaemic patients in a single centre: clinical features and laboratory findings.
  - Molecular characterization of 9 genetic defects responsible for FV deficiency
Assi Z. - Strategy of thrombus removal for iliofemoral dvt of pregnancy
Astermark J. - A prospective, randomized trial of daily prophylaxis in hemophilia
  - APCC in combination with FVIII potentiate in vitro thrombin production in inhibitor plasma
  - Impact on thrombin generation of different factor VIII concentrates in patients with acquired haemophilia
  - A pharmacokinetic study: impact on thrombin generation of two recombinant factor VIII concentrates in subjects with haemophilia A
  - Non-inhibitory antibodies in the MIBS cohort
Astudillo O.G. - Effects of short-term glucocorticoids on von Willebrand factor in mice. Preliminary results
Asvold B.O. - Increased levels of thyroxin increase the risk of venous thrombosis
Ataga K.I. - Activation of coagulation in sickle cell trait; possible role for circulating microparticle tissue factor
  - Thrombin generation and fibrin clot formation in patients with sickle cell disease (SCD)
Atalar A. - Effectivity of intraarticular hyaluronic acid in hemophilic artropathy
Atalay C.S. - Results of a multicenter, cross-sectional venous thrombosis screening study in Izmir
Atanasov B.P. - Physicochemical characterization of factor VIII neutralization by an inhibitory antibody
Atanasova S. - The management of elevated APL in pregnancy
  - Laboratory monitoring of heparinemy
Atarodi K. - A comparison of the prevalence of hereditary natural anticoagulant pathway defects between patients with DVT, PE and thrombosis at unusual sites
Ataullakhanov F.I. - Task-oriented modular analysis of the blood coagulation network: the role of factor V feedback activation in triggering clot formation
  - New thrombin inhibitors: strategy of molecular design and experimental testing
  - Regulatory functions of positive feedbacks of factors V and VII activation in blood clotting initiation
Athale U. - Elevated levels of FVIIa-at following prednisone monotherapy in children with newly diagnosed acute lymphoblastic leukemia
  - Decreased overall survival and increased risk of thrombosis in children with cancer and central venous line (CVL) dysfunction
  - Production of VWF may mediate lymphoblast induced thrombin activation in children with newly diagnosed ALL
Atilla B. - Venous thromboembolism prophylaxis after major orthopedic surgery: a multi-center prospective observational study
Atkinson H.M. - Anticoagulant mechanisms of antithrombin-heparin studied by TEG
  - Comparison of recombinant and plasma-derived antithrombin biodistribution in vivo
Atmaca S. - Immune thrombocytopenic purpura-related hemotympanum presenting with hearing loss
Atsumi T. - The p38 mitogen-activate protein kinase (MAPK) pathway mediates the induction of tissue factor and adhesion molecule expressions on endothelial cells
ATSUMI G. - Inhibition of PAI-1 production by treatment of herbal medicine in human umbilical vein endothelial cells
Atsumi T. - Predictive value of the antiphospholipid score (aPL-S) for thrombotic events in patients with autoimmune diseases
  - Nicked beta2-glycoprotein I, but not intact beta2-glycoprotein I, binds plasminogen proteolysis product angiostatin4.5 and reduce its physiological properties
Attias D. - Relapsing catstrophic antiphospholipid syndrome associated with early onset hellp syndrome and liver infarctions
Attilio M. - Release of pentraxin-3 from activated neutrophil modulates platelet-neutrophil cross-talk
Attwood S.J. - Strategy for the use of single molecule force spectroscopy to investigate binding of integrin integrin alpha(2)beta(1) and collagen
Auerswald G. - Symptomatic congenital disorders of fibrinogen – effective treatment with fibrinogen concentrate?
  - Prospective study of inhibitor incidence with continuous infusion of factor concentrates during and after surgical procedures in patients with haemophilia A, B, or von Willebrand disease
Auh H. - Platelet upregulation in mice exposed to ambient particulate matter
Aujesky D. - Simplification of the Pulmonary Embolism Severity Index for prognosticating patients with acute symptomatic pulmonary embolism
  - Complete venous ultrasound in outpatients with suspected pulmonary embolism
  - Short-term prognosis of pulmonary embolism
  - Interobserver reproducibility of clinical probability assessment in suspected pulmonary embolism: revised geneva score and wells score
Aung P.P. - P2RY1 gene polymorphisms are associated with aspirin resistance in patients with a history of myocardial infarction
Austin R.C. - Activated protein C (APC) inhibits inflammation and apoptosis by regulating endoplasmic reticulum (ER) stress
Austin H. - The relationship between the A6963G EPCR polymorphism and venous thromboembolism in American whites and blacks: the gate study
  - The relationship of two polymorphisms of the TCF7l2 gene and venous thromboembolism in American whites and blacks: the gate study
  - Lack of association between the PHE204 allele of factor XIII with venous thromboembolism and myocardial infarction
  - Factor V Leiden and venous thromboembolism risk among idiopathic and provoked cases in the gate study
  - Polymorphisms in the thrombin-activatable fibrinolysis inhibitor gene and risk of venous thromboembolism
Austin S. - Management of acquired haemophilia A - a single centre experience
Austinat M. - Deficiency of von Willebrand factor protects mice from ischemic stroke
Averett L.E. - Forced rupture of fibrin ‘A-a’ knob-hole interaction is accompanied by unfolding in the distal D region of the molecule
Averkov O. - Unfractionated heparin or fondaparinux in elderly patients with non-ST-elevation acute coronary syndrome: different effect on fibrinolytic status at day 8
Averna M. - Decreased plasma soluble rage in patients with hypercholesterolemia: effects of statins
  - Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose
Avery G. - Incidental splanchnic thrombosis in cancer patients
Avidan M. - Prediction and management of bleeding in cardiac surgery
Awodu O.A. - Lupus anticoagulant in Nigerian women with poor obstetrics history
  - Hemostasis and hematological thrombotic risk factors in young Nigerian SemiVegetarians
  - Anthropometric and haemostatic cardiovascular risk in young Nigerian semi vegetarians
  - Haemostatic profile and determinants of rheology in nigerian pre-eclamptics
  - Effects of anti-retroviral therapy on haemostatic and haemorheological parameters in HIV/AIDS patients
  - Haemostatic and haemorheological changes in african patients with acute lymphoblastic leukaemia
  - Haemostatic and haemorheological changes in African patients with chronic myeloid leukaemia
Ay Y. - Long-term evaluation of chromosomal breakages after radioisotope synovectomy for treatment of target joints in patients with hemophilia
Ay C. - Deficiency of plasminogen activator inhibitor type 1 (PAI-1) and alpha2-antiplasmin (APL) activity in patients with a bleeding tendency of unknown origin
  - Factor V Leiden mutation increases the risk for venous thromboembolism in patients with malignancy
  - High levels of serum immunoglobulin G predict the risk of thrombosis in patients with the lupus anticoagulant (LAC)
  - Elevated C-reactive protein (CRP) levels are associated with risk of occurrence of venous thromboembolism (VTE) in cancer patients – results from the vienna cancer and thrombosis study (CATS)
  - Prediction of venous thromboembolism in cancer patients by measuring thrombin generation –results from the vienna cancer and thrombosis study (CATS)
  - Biomarkers improve the risk scoring model for prediction of cancer-associated thrombosis
Ayachi O. - Alternatively spliced tissue factor promotes angiogenesis through integrin ligation
Ayad A.S. - Titre: evaluation of the occurrence incidence of anti-F VIII inhibitors in haemophilia: Algerian study
Ayad S. - Severe bleeding due to acquired hypoprothrombinemia-lupus anticoagulant syndrome: case report and review of literature
Ayares D. - Tissue factor expression on recipient platelets and PBMCs is the key factor in coagulation dysfunction in pig-to-primate liver transplantation
Ayats J. - Minimally-invasive parathyroidectomy with recombinant activated FVII in GLANZMANN′S thrombasthenia
Ayaz S. - Evaluation of hematologic factors in young and elderly candidates for coronary artery bypass grafting
  - Measurement of the procoagulant activity of factor vii in patients with liver cirrhosis and normal prothrombin activity : evaluation of the bleeding risk
Ayaz Ozkul A. - Hemostatic changes in cyanotic and acyanotic congenital heart diseases
Aydogan G. - Immun thrombocytopenic purpura in children with therapy modalities
  - RFVIIA treatment in factor VII deficiency: a single centre experience
  - The comprehensive, multidisciplinary team for the treatment of haemophilia: istanbul experience
Aydogdu S. - Long-term evaluation of chromosomal breakages after radioisotope synovectomy for treatment of target joints in patients with hemophilia
Ayers D. - Bleeding concerns drive practices of orthopedic surgeons in prevention of venous thromboembolism in primary hip and knee arthroplasty
Aygören Pürsün E. - Hereditary angioedema due to missense mutations in the coagulation factor XII gene - three novel cases
Aygören-Pürsün E. - Self administration of C1-inhibitor-concentrate in patients with hereditary angiodema (HAE)
  - Age-related reference ranges of C1-INH activity and antigen are important for early diagnosis in paediatric HAE patients
Ayob Y. - VWF:CB and VWF:RCo. Assay to differentiate between type 1 and type 2 von Willebrand disease in national blood centre
Azari B.M. - F11R/JAM-a is required for platelet adhesion to inflamed endothelial cells (EC): role in thrombogenesis and atherosclerosis
Azevedo M. - Generation and phenotypic analysis of protein s-deficient mice
Azibani F. - Protease nexin-1 is anti-angiogenic in vitro independently of its anti-protease activity
Aznar J.A. - High-dose immunotolerance treatment three times a week in a severe haemophilia A patient
  - FVIII inhibitor epitope mapping in haemophilia A patients
  - Gynecologic and obstetric pathologies in women with severe bleeding disorders: experience at a reference coagulopathies unit in spain
  - Phenotype-genotype correlation in mild hemophilia A
Aznar M. - Recombinant activated factor VII prophylactic treatment for intracranial hemorrhage in a hemophilia patient with inhibitors
Aznar J.A. - Menorrhagia in women with von Willebrand disease: experience in a reference congenital coagulopathies unit in Spain
Azzam N. - Natural anticoagulants can be useful predictors of severity in chronic liver disease
Azzaoui R. - Tissue factor pathway inhibitor-2 gene methylation in carotid atherosclerotic plaques